Vivos Therapeutics reports mixed Q1 results, aims for growth By Investing.com
Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million...
Vivos
Vivos Therapeutics, a company specializing in the treatment of obstructive sleep apnea (OSA), reported a total revenue of $3.4 million...
